Intravitreal Ranibizumab (Lucentis) for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis of Randomized Clinical Control Trials

Intravitreal Anti-VEGF Therapy with Prompt or Deferred Laser Compared with Steroid with Prompt Laser and Prompt Laser Alone for Treatment of Diabetic Macular Edema

(2011) Jennifer K. Sun   Current Diabetes Reports

Comparison of Intravitreal Bevacizumab and Ranibizumab Treatment for Diabetic Macular Edema

(2011) Banu Turgut Ozturk et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

(2011) Michael J. Elman et al.   OPHTHALMOLOGY

The RESTORE Study

(2011) Paul Mitchell et al.   OPHTHALMOLOGY

RANDOMIZED TRIAL EVALUATING SHORT-TERM EFFECTS OF INTRAVITREAL RANIBIZUMAB OR TRIAMCINOLONE ACETONIDE ON MACULAR EDEMA AFTER FOCAL/GRID LASER FOR DIABETIC MACULAR EDEMA IN EYES ALSO RECEIVING PANRETINAL PHOTOCOAGULATION

(2011) Joseph Googe et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

(2010) P. Massin et al.   DIABETES CARE

Meta-analysis and review on the effect of bevacizumab in diabetic macular edema

(2010) Sunali Goyal et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Glucose regulation influences treatment outcome in ranibizumab treatment for diabetic macular edema

(2010) Banu Turgut Ozturk et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2010) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

(2010) Michael J. Elman et al.   OPHTHALMOLOGY

The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 Diabetes

(2009) Ronald Klein et al.   OPHTHALMOLOGY

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2009) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY

Epidemiology of Diabetes and Diabetes-Related Complications

(2008) Anjali D Deshpande et al.   PHYSICAL THERAPY

Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study)

(2007) Matheus Tonello et al.   ACTA OPHTHALMOLOGICA